DE69533437D1 - Makroeingekapselte sekretorische zellen - Google Patents

Makroeingekapselte sekretorische zellen

Info

Publication number
DE69533437D1
DE69533437D1 DE69533437T DE69533437T DE69533437D1 DE 69533437 D1 DE69533437 D1 DE 69533437D1 DE 69533437 T DE69533437 T DE 69533437T DE 69533437 T DE69533437 T DE 69533437T DE 69533437 D1 DE69533437 D1 DE 69533437D1
Authority
DE
Germany
Prior art keywords
secretoric
macro
enclosed
cells
agarose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69533437T
Other languages
English (en)
Other versions
DE69533437T2 (de
Inventor
Kanti Jain
Albert L Rubin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rogosin Institute Inc
Original Assignee
Rogosin Institute Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rogosin Institute Inc filed Critical Rogosin Institute Inc
Publication of DE69533437D1 publication Critical patent/DE69533437D1/de
Application granted granted Critical
Publication of DE69533437T2 publication Critical patent/DE69533437T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/39—Pancreas; Islets of Langerhans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/04—Enzymes or microbial cells immobilised on or in an organic carrier entrapped within the carrier, e.g. gel or hollow fibres
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0012—Cell encapsulation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0676—Pancreatic cells
    • C12N5/0677—Three-dimensional culture, tissue culture or organ culture; Encapsulated cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/126—Immunoprotecting barriers, e.g. jackets, diffusion chambers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C12N2533/54—Collagen; Gelatin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/70—Polysaccharides
    • C12N2533/76—Agarose, agar-agar

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Dispersion Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69533437T 1994-01-13 1995-01-12 Makroeingekapselte sekretorische zellen Expired - Lifetime DE69533437T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18126994A 1994-01-13 1994-01-13
US181269 1994-01-13
PCT/US1995/000400 WO1995019430A1 (en) 1994-01-13 1995-01-12 Macroencapsulated secretory cells

Publications (2)

Publication Number Publication Date
DE69533437D1 true DE69533437D1 (de) 2004-10-07
DE69533437T2 DE69533437T2 (de) 2005-09-15

Family

ID=22663563

Family Applications (3)

Application Number Title Priority Date Filing Date
DE69535842T Expired - Lifetime DE69535842D1 (de) 1994-01-13 1995-01-12 Makroeingekapselte sekretorische Zellen
DE69533437T Expired - Lifetime DE69533437T2 (de) 1994-01-13 1995-01-12 Makroeingekapselte sekretorische zellen
DE69534865T Expired - Lifetime DE69534865T2 (de) 1994-01-13 1995-01-12 Makroeingekapselte sekretorische Zellen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE69535842T Expired - Lifetime DE69535842D1 (de) 1994-01-13 1995-01-12 Makroeingekapselte sekretorische Zellen

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69534865T Expired - Lifetime DE69534865T2 (de) 1994-01-13 1995-01-12 Makroeingekapselte sekretorische Zellen

Country Status (19)

Country Link
US (3) US5643569A (de)
EP (3) EP0742818B1 (de)
JP (4) JP3948742B2 (de)
KR (1) KR100474803B1 (de)
CN (1) CN1087779C (de)
AT (3) ATE320482T1 (de)
AU (1) AU681240C (de)
CA (1) CA2181156C (de)
DE (3) DE69535842D1 (de)
DK (2) DK1418228T3 (de)
ES (3) ES2260568T3 (de)
FI (1) FI118853B (de)
HK (1) HK1084693A1 (de)
IL (1) IL112330A (de)
NO (2) NO323228B1 (de)
NZ (3) NZ278809A (de)
PT (3) PT1418228E (de)
RU (2) RU2208636C2 (de)
WO (1) WO1995019430A1 (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830492A (en) * 1992-02-24 1998-11-03 Encelle, Inc. Bioartificial devices and cellular matrices therefor
US5834005A (en) * 1992-02-24 1998-11-10 Encelle, Inc. Bioartificial devices and cellular matrices therefor
US6231881B1 (en) 1992-02-24 2001-05-15 Anton-Lewis Usala Medium and matrix for long-term proliferation of cells
US5824331A (en) * 1992-02-24 1998-10-20 Encelle, Inc. Bioartificial devices and cellular matrices therefor
ES2260568T3 (es) * 1994-01-13 2006-11-01 The Rogosin Institute Celulas secretoras macroencapsuladas.
USRE39542E1 (en) * 1994-01-13 2007-04-03 The Rogosin Institute Preparation of agarose coated, solid agarose-collagen beads containing secretory cells
US5916790A (en) * 1995-03-03 1999-06-29 Metabolex, Inc. Encapsulation compositions, and methods
JPH11501512A (ja) * 1995-03-03 1999-02-09 メタボレックス，インコーポレイティド ゲル化ポリマーによる新規の被包方法
US6419920B1 (en) 1995-10-25 2002-07-16 Trans Karyotic Therapies, Inc. Hybrid matrix implants and explants
US5965125A (en) * 1995-10-25 1999-10-12 Transkaryotic Therapies, Inc. Hybrid matrix implants and explants
AU6496996A (en) * 1996-02-23 1997-09-10 Circle Biomedical, Inc. Novel artificial pancreas
US7297331B2 (en) 1996-04-03 2007-11-20 The Rogosin Institute Beads containing restricted cancer cells producing material suppressing cancer cell proliferation
US5888497A (en) * 1996-04-03 1999-03-30 The Rogosin Institute Agarose coated agarose beads containing cancer cells that produce material which suppresses cancer cell proliferation
KR100477296B1 (ko) * 1996-04-03 2005-05-16 더 로고신 인스티튜트 확산성의생물학적산물생산세포를함유하는이식가능한아가로오스-콜라겐비드,및그의용도
DE69738170T2 (de) * 1996-04-03 2008-01-24 The Rogosin Institute Konditioniertes Medium und diffusionsfähiges biologisches Material gewonnen durch Inkubierung von eingeschlossenen Zellen
US6224912B1 (en) 1996-04-03 2001-05-01 The Rogo Institute Cancer-cell proliferation-suppressing material produced by cancer cells restricted by entrapment
US6303151B1 (en) * 1996-04-03 2001-10-16 The Rogosin Institute Cancer-cell proliferation-suppressing material produced by cancer cells restricted by entrapment
KR100547402B1 (ko) 1996-09-13 2006-02-01 트랜스케리오틱 쎄러피스, 인코포레이티드 α-갈락토시다아제 Ａ 결핍을 치료하는 방법
AU8577498A (en) * 1997-07-22 1999-02-16 General Hospital Corporation, The Modulation of multicellular aggregates by solid stress
US5922339A (en) * 1998-01-27 1999-07-13 Usala; Anton-Lewis Compositions and methods for biocompatible implants
US6365385B1 (en) * 1999-03-22 2002-04-02 Duke University Methods of culturing and encapsulating pancreatic islet cells
US6303355B1 (en) 1999-03-22 2001-10-16 Duke University Method of culturing, cryopreserving and encapsulating pancreatic islet cells
US6391576B1 (en) * 1999-10-13 2002-05-21 Japan Bioindustry Association Method for isolating a microbe
US6279656B1 (en) 1999-11-03 2001-08-28 Santrol, Inc. Downhole chemical delivery system for oil and gas wells
WO2001091774A2 (en) 2000-05-31 2001-12-06 Encelle, Inc. Method of treating chronic ulcers
JP2006516134A (ja) * 2002-12-24 2006-06-22 アン−ゴ−ゲン・インコーポレイテッド 封入化細胞療法
WO2004075855A2 (en) 2003-02-26 2004-09-10 Biomed Solutions, Llc Process for in vivo treatment of specific biological targets in bodily fluid
US20050053586A1 (en) 2003-09-04 2005-03-10 Bryan Conn Entrapped stem cells and uses thereof
US20060121077A1 (en) * 2004-11-11 2006-06-08 Lawrence Gazda Method for treating patients with implants of islets which have been kept in long term, in vitro culture
CA2622529C (en) * 2005-09-26 2014-02-18 Lawrence Gazda Secretory cell-containing macrobeads comprising seakem gold agarose, and uses thereof
US20070116680A1 (en) * 2005-11-18 2007-05-24 Rensselaer Polytechnic Institute Stem cells within gel microenvironments
EP2029727B1 (de) * 2006-06-16 2012-04-11 FMC Biopolymer AS Alginatbeschichtete collagenmatrix-zellvorrichtung, herstellungsverfahren dafür und verwendungen davon
US20100124775A1 (en) * 2007-01-24 2010-05-20 Koninklijke Philips Electronics N.V. Process for treating cultured cells
AU2008289461A1 (en) 2007-08-23 2009-02-26 Intrexon Corporation Methods and compositions for diagnosing disease
EP2205249B1 (de) 2007-09-28 2018-11-07 Intrexon Corporation Therapeutische genschalterkonstrukte und bioreaktoren zur expression biotherapeutischer moleküle und ihre verwendung
DE102010040687A1 (de) 2010-09-14 2012-03-15 Hamilton Bonaduz Ag Verfahren zum Herstellen von Wirkstoff-Beads
US10655120B2 (en) 2011-03-21 2020-05-19 The University Of Newcastle Upon Tyne Transport of cells in hydrogels
DE102011050024A1 (de) 2011-04-29 2012-10-31 Hamilton Bonaduz Ag Analysevorrichtung für eine berührungslose Analyse der Ausformung eines transparenten Körpers und Verfahren zur Durchführung der berührungslosen Analyse
HUE034618T2 (en) 2012-01-31 2018-02-28 The Rogosin Inst Inc An improved process for producing macros
KR101327630B1 (ko) * 2012-03-05 2013-11-13 울산대학교 산학협력단 아텔로콜라겐을 이용한 췌도세포 이식용 담체의 제조방법 그리고 이를 이용하여 제조된 인공췌장
UY38389A (es) 2018-09-27 2020-04-30 Sigilon Therapeutics Inc Dispositivos implantables para terapia celular y métodos relacionados
WO2024081309A1 (en) 2022-10-11 2024-04-18 Sigilon Therapeutics, Inc. Engineered cells and implantable elements for treatment of disease
WO2024081310A1 (en) 2022-10-11 2024-04-18 Sigilon Therapeutics, Inc. Engineered cells and implantable elements for treatment of disease

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4391909A (en) * 1979-03-28 1983-07-05 Damon Corporation Microcapsules containing viable tissue cells
US4352883A (en) * 1979-03-28 1982-10-05 Damon Corporation Encapsulation of biological material
US4409331A (en) * 1979-03-28 1983-10-11 Damon Corporation Preparation of substances with encapsulated cells
SE441009B (sv) * 1982-03-08 1985-09-02 Kjell Nilsson Sett att immobilisera levande biomaterial i perlformiga polymerer
US4798786A (en) * 1982-05-06 1989-01-17 Stolle Research And Development Corporation Living cells encapsulated in crosslinked protein
CA1196862A (en) * 1983-06-01 1985-11-19 Anthony M.F. Sun Microencapsulation of living tissue and cells
US4663286A (en) * 1984-02-13 1987-05-05 Damon Biotech, Inc. Encapsulation of materials
US4997443A (en) * 1985-08-26 1991-03-05 Hana Biologics, Inc. Transplantable artificial tissue and process
US4902295A (en) * 1985-08-26 1990-02-20 Hana Biologics, Inc. Transplantable artificial tissue
SE8604684L (sv) * 1986-11-03 1988-05-04 Excorim Kommanditbolag Sett att belegga fasta partiklar med en hydrofil gel samt genom settet belagda partiklar
US5053332A (en) * 1989-07-24 1991-10-01 Cook Richard B Agarose beads, preferably incorporating biological materials
US5227298A (en) * 1990-08-17 1993-07-13 The Trustees Of Columbia University In The City Of New York Method for microencapuslation of cells or tissue
FR2686250A1 (fr) * 1992-01-16 1993-07-23 Coletica Compositions injectables contenant en suspension des microcapsules a base de collagene, leur utilisation biomedicale et des compositions pharmaceutiques.
WO1993024076A1 (en) * 1992-05-29 1993-12-09 The Regents Of The University Of California Coated transplant and method for making same
WO1994012161A1 (en) * 1992-11-24 1994-06-09 Clover Consolidated, Limited Cytoprotective, biocompatible, retrievable macrocapsules
ES2260568T3 (es) * 1994-01-13 2006-11-01 The Rogosin Institute Celulas secretoras macroencapsuladas.
US5888497A (en) * 1996-04-03 1999-03-30 The Rogosin Institute Agarose coated agarose beads containing cancer cells that produce material which suppresses cancer cell proliferation
US6224912B1 (en) * 1996-04-03 2001-05-01 The Rogo Institute Cancer-cell proliferation-suppressing material produced by cancer cells restricted by entrapment

Also Published As

Publication number Publication date
IL112330A (en) 1999-01-26
DK1666585T3 (da) 2009-01-12
NZ278809A (en) 1998-03-25
CN1141650A (zh) 1997-01-29
NZ329619A (en) 1999-09-29
FI962841A0 (fi) 1996-07-12
USRE38027E1 (en) 2003-03-11
DE69534865T2 (de) 2006-08-17
FI962841A (fi) 1996-09-12
EP0742818A1 (de) 1996-11-20
JP2005137376A (ja) 2005-06-02
PT1666585E (pt) 2008-12-10
RU2177503C2 (ru) 2001-12-27
FI118853B (fi) 2008-04-15
ES2227544T3 (es) 2005-04-01
EP1666585B1 (de) 2008-09-10
US5643569A (en) 1997-07-01
KR20050005235A (ko) 2005-01-13
DE69535842D1 (de) 2008-10-23
NO962955L (no) 1996-09-11
DE69534865D1 (de) 2006-05-11
RU2208636C2 (ru) 2003-07-20
AU1526795A (en) 1995-08-01
DK1418228T3 (da) 2006-07-17
EP0742818B1 (de) 2004-09-01
EP1418228A1 (de) 2004-05-12
ATE320482T1 (de) 2006-04-15
ES2260568T3 (es) 2006-11-01
JP2007020585A (ja) 2007-02-01
JP2006345875A (ja) 2006-12-28
DE69533437T2 (de) 2005-09-15
KR100474803B1 (ko) 2005-03-10
EP0742818A4 (de) 2002-01-09
JPH09510868A (ja) 1997-11-04
ATE408005T1 (de) 2008-09-15
JP3948742B2 (ja) 2007-07-25
EP1418228B1 (de) 2006-03-15
HK1084693A1 (en) 2006-08-04
NZ509363A (en) 2006-02-24
ATE275194T1 (de) 2004-09-15
EP1666585A1 (de) 2006-06-07
NO962955D0 (no) 1996-07-15
IL112330A0 (en) 1995-03-30
NO324570B1 (no) 2007-11-26
CA2181156C (en) 2001-10-16
JP3989492B2 (ja) 2007-10-10
PT1418228E (pt) 2006-09-29
NO20051359L (no) 1996-09-11
WO1995019430A1 (en) 1995-07-20
AU681240C (en) 2006-12-07
PT742818E (pt) 2004-12-31
USRE40555E1 (en) 2008-10-28
CN1087779C (zh) 2002-07-17
AU681240B2 (en) 1997-08-21
MX9602765A (es) 1998-06-30
NO323228B1 (no) 2007-02-05
JP4435134B2 (ja) 2010-03-17
ES2309849T3 (es) 2008-12-16
CA2181156A1 (en) 1995-07-20

Similar Documents

Publication Publication Date Title
ATE320482T1 (de) Makroeingekapselte sekretorische zellen
FI972701A (fi) Menetelmä päätelaitteiden käytön rajoittamiseksi
DE69734631D1 (de) Sonnenzelle, und Montage- und Herstellungsmethode dafür
DE69603416D1 (de) Elektrochemischer Immunobiosensor
DE69706783T2 (de) Gasdichte Bleisäurebatterie
DE69718481T2 (de) Elektrolyt
BR9507784A (pt) Regulador elétrico
DE59510541D1 (de) Elektrochemische Zelle
BR9607041A (pt) Célula eletroquímica primário
BR9610196A (pt) Pilha eletroquímica
DE69608686D1 (de) Gewickelte elektrochemische zelle, herstellungsverfahren und verwendung der zelle
DE69508059D1 (de) Elektrode für elektrochemische bearbeitung
ID18992A (id) Pelawan interleukin-4 selektif sel-t
DE69620144D1 (de) Stromspeicherzelle
DE69617383D1 (de) Stromspeicherzelle
DE59604231D1 (de) Gasdurchlässige hochspannungsisolation
KR960009368U (ko) 정전압 충전기
FI945329A0 (fi) Testanlaeggning foer en basstation i en utvidgad cell
KR950031467U (ko) 이온 주입 조절장치
BR9403106A (pt) Eletrodo de referência de eletrólito sólido
KR960005887U (ko) 전기식 뇌관
DK0742818T3 (da) Makroindkapslede sekretoriske celler
KR960003488U (ko) 스피커 셀 구조
KR970006225U (ko) 양측전원 단자를 구비한 환풍기
DE29604206U1 (de) Innenraumzelle

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: WEICKMANN & WEICKMANN, 81679 MUENCHEN